On the expression of fractalkine by rosiglitazone in human renal mesangial cells induced by advanced glycation end products / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 660-661, 2008.
Article
in Chinese
| WPRIM
| ID: wpr-397356
ABSTRACT
The effect of rosiglitazone and advanced glycation end products (AGEs) on the expression of fractalkine in cultured human renal mesangial cells (HRMC) were investigated. Rosiglitazone inhibits the upregulation of fractalkine induced by AGEs in HRMC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS